Check out our most popular compounded medications! Get Started
Metoprolol Tartrate 12.5 mg Slow Release Capsules (Gluten Free) are designed to treat conditions such as hypertension, angina, heart failure, atrial fibrillation, and arrhythmia. These capsules are formulated with Methocel E4M, a controlled-release polymer, which ensures the gradual and extended release of the active ingredient. This slow release formulation offers sustained therapeutic effects, reduces dosing frequency, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Metoprolol Tartrate 12.5 mg Slow Release Capsules (Gluten Free) is a specialized medication designed to treat a range of cardiovascular conditions, including hypertension, angina, heart failure, atrial fibrillation, and myocardial infarction. This formulation is uniquely crafted with Methocel E4M, a controlled-release polymer, which ensures a gradual and sustained release of the active ingredient, metoprolol tartrate, over an extended period. This slow-release mechanism allows for consistent therapeutic effects, reduced dosing frequency, and improved patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
Metoprolol tartrate, the active ingredient, is a beta-blocker that functions by inhibiting the action of certain hormones in the body, such as epinephrine. This action helps to lower blood pressure and heart rate, thereby reducing the risk of stroke, heart attack, and other cardiovascular complications in patients with hypertension. For patients with angina, metoprolol tartrate can alleviate chest pain and enhance exercise tolerance. In heart failure treatment, it can help to alleviate symptoms and improve the patient's quality of life. For those with atrial fibrillation, metoprolol tartrate can help to lower the risk of stroke and other complications. In the treatment of myocardial infarction, it can help to reduce the risk of death and other complications.
This formulation is also gluten-free, making it a suitable choice for patients with gluten sensitivities or celiac disease. Metoprolol Tartrate 12.5 mg Slow Release Capsules (Gluten Free) is a comprehensive medication solution for the management of various cardiovascular conditions. If you have any questions about this formulation or its use, please do not hesitate to reach out for more information.
Metoprolol Tartrate 12.5 mg Slow Release Capsules (Gluten Free) is a compounded formulation designed to provide a controlled and prolonged release of the active ingredient, Metoprolol Tartrate. This medication is primarily used in the treatment of hypertension, angina, heart failure, atrial fibrillation, and myocardial infarction. As a beta-blocker, it functions by inhibiting the action of certain natural chemicals in the body, such as epinephrine, on the heart and blood vessels. This action helps to lower blood pressure, reduce heart rate, and alleviate strain on the heart.
Additionally, Metoprolol Tartrate 12.5 mg Slow Release Capsules (Gluten Free) is used to prevent angina (chest pain) and to improve survival rates after a heart attack. The slow-release formulation, made possible by the use of Methocel E4M, a controlled-release polymer, allows for a reduced dosing frequency, which can lead to improved patient compliance. This medication is typically taken once daily, with or without food, and it is crucial to adhere to the prescribed dosage for maximum therapeutic benefits.
Common side effects of Metoprolol Tartrate 12.5 mg Slow Release Capsules (Gluten Free) may include dizziness, fatigue, and nausea. If any of these side effects are experienced, it is recommended to contact a healthcare professional. It is also important to note that this medication should be taken regularly to achieve the most benefit. If you have any questions about using Metoprolol Tartrate 12.5 mg Slow Release Capsules (Gluten Free) for any of the aforementioned conditions, please consult with your healthcare provider.
Metoprolol Tartrate 12.5 mg Slow Release Capsules (Gluten Free) is a specially formulated medication designed to manage various cardiovascular conditions such as hypertension, angina, heart failure, atrial fibrillation, and myocardial infarction. This medication operates by inhibiting the action of certain chemicals in the body that can cause the heart to beat faster and with more force. As a result, it aids in lowering blood pressure and enhancing the heart's ability to pump blood.
The capsules are formulated with Methocel E4M, a type of controlled-release polymer. This innovative design allows for the gradual release of the encapsulated medication or active ingredient over an extended period of time. This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.
Metoprolol Tartrate 12.5 mg Slow Release Capsules (Gluten Free) is administered orally, typically once a day. It is crucial to adhere to the medication regimen as prescribed by your healthcare provider and to avoid missing doses. Regular monitoring of your blood pressure while on this medication is also essential. If you experience any side effects such as dizziness, lightheadedness, or chest pain, it is important to contact your healthcare provider immediately.
If you have any queries about Metoprolol Tartrate 12.5 mg Slow Release Capsules (Gluten Free) or any other medication, please do not hesitate to reach out to us at Bayview Pharmacy. We are here to assist you with your medication needs and to provide you with the necessary information to ensure safe and appropriate use of your medications.
Metoprolol Tartrate 12.5 mg Slow Release Capsules (Gluten Free) are meticulously formulated with Methocel E4M, a type of controlled-release polymer. This advanced formulation is designed to gradually release the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism reduces the need for frequent dosing and enhances patient compliance, particularly for medications requiring a controlled and prolonged release profile.
These capsules are versatile in their therapeutic applications. They can be used to manage a variety of conditions such as migraine headaches, tremors, and anxiety. Furthermore, they can be used to decrease the risk of mortality in patients with specific types of heart failure and to lower the risk of a heart attack in those with certain types of coronary artery disease.
Metoprolol Tartrate 12.5 mg Slow Release Capsules (Gluten Free) are also beneficial in managing high blood pressure in pregnant women. They can be used to treat certain types of chest pain, known as angina, and to improve survival rates following a heart attack. If you have any queries regarding the use of Metoprolol Tartrate 12.5 mg Slow Release Capsules (Gluten Free) for any of these conditions, please do not hesitate to contact us.
Metoprolol Tartrate 12.5 mg Slow Release Capsules are a type of medication that is designed to be released gradually over an extended period of time. This is achieved through the use of a controlled-release polymer known as Methocel E4M.
The benefit of using this medication is that it offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance. This is particularly beneficial for medications that require a controlled and prolonged release profile.
Methocel E4M is a type of controlled-release polymer that is used in the formulation of Metoprolol Tartrate 12.5 mg Slow Release Capsules. It is designed to release the encapsulated medication or active ingredient gradually over an extended period of time.
Methocel E4M works by gradually releasing the encapsulated medication or active ingredient over an extended period of time. This allows for sustained therapeutic effects and reduced dosing frequency.
'Controlled-release' refers to the process by which a medication is designed to be released gradually over an extended period of time. This is achieved through the use of a controlled-release polymer, such as Methocel E4M.
'Sustained therapeutic effects' refers to the ongoing benefits of a medication over an extended period of time. This is achieved through the use of a controlled-release polymer, such as Methocel E4M, which allows for the gradual release of the medication.
'Reduced dosing frequency' refers to the need for fewer doses of a medication over a given period of time. This is achieved through the use of a controlled-release polymer, such as Methocel E4M, which allows for the gradual release of the medication.
'Improved patient compliance' refers to the increased likelihood of a patient adhering to their medication regimen. This is achieved through the use of a controlled-release polymer, such as Methocel E4M, which allows for the gradual release of the medication and a reduced dosing frequency.
Yes, Metoprolol Tartrate 12.5 mg Slow Release Capsules are gluten free.
Medications that require a controlled and prolonged release profile are typically those that need to be taken over an extended period of time, such as those for chronic conditions. The use of a controlled-release polymer, such as Methocel E4M, allows for the gradual release of the medication, offering sustained therapeutic effects and improved patient compliance.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
